Camp4 Therapeutics Management
Management criteria checks 2/4
Camp4 Therapeutics' CEO is Josh Mandel-Brehm, appointed in Jan 2017, has a tenure of 8.33 years. total yearly compensation is $2.29M, comprised of 24.3% salary and 75.7% bonuses, including company stock and options. directly owns 1.35% of the company’s shares, worth $607.23K. The average tenure of the management team and the board of directors is 3.8 years and 8.3 years respectively.
Key information
Josh Mandel-Brehm
Chief executive officer
US$2.3m
Total compensation
| CEO salary percentage | 24.28% |
| CEO tenure | 8.3yrs |
| CEO ownership | 1.4% |
| Management average tenure | 3.8yrs |
| Board average tenure | 8.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | -US$52m |
| Dec 31 2024 | US$2m | US$557k | -US$52m |
| Sep 30 2024 | n/a | n/a | -US$52m |
| Jun 30 2024 | n/a | n/a | -US$50m |
| Mar 31 2024 | n/a | n/a | -US$49m |
| Dec 31 2023 | US$696k | US$546k | -US$49m |
Compensation vs Market: Josh's total compensation ($USD2.29M) is above average for companies of similar size in the US market ($USD647.92K).
Compensation vs Earnings: Josh's compensation has increased whilst the company is unprofitable.
CEO
Josh Mandel-Brehm (41 yo)
Mr. Joshua Mandel-Brehm, also known as Josh, serves as an Independent Director at ProMIS Neurosciences, Inc. September 2021 and served as its Director since September 1, 2021. He has also been a founder an...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 8.3yrs | US$2.29m | 1.35% $ 607.2k | |
| Founder & Independent Director | no data | US$143.05k | 0.77% $ 345.3k | |
| Chief Financial Officer | no data | US$1.31m | 0.31% $ 137.8k | |
| Chief Medical Officer | 1.8yrs | US$2.52m | 0% $ 0 | |
| Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| Chief Business Operations Officer & SVP of Portfolio Strategy & Business Operations | no data | no data | no data | |
| Chief Scientific Officer & Senior Vice President of Research | 5.2yrs | US$501.93k | 0.31% $ 137.7k | |
| Senior VP & Chief People Officer | 3.8yrs | no data | no data | |
| Senior Vice President of Technical Operations | 2.7yrs | no data | no data | |
| VP & Head of Discovery | no data | no data | no data |
Experienced Management: CAMP's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 8.3yrs | US$2.29m | 1.35% $ 607.2k | |
| Founder & Independent Director | 9.3yrs | US$143.05k | 0.77% $ 345.3k | |
| Founder & Chairman of Scientific Advisory Board | no data | no data | no data | |
| Independent Chairman of the Board | 5.6yrs | US$132.72k | 0.54% $ 242.9k | |
| Independent Director | 10.3yrs | no data | no data | |
| Independent Director | 8.3yrs | US$46.36k | 0.14% $ 64.1k | |
| Independent Director | 6yrs | US$44.15k | 0.10% $ 45.1k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
Experienced Board: CAMP's board of directors are considered experienced (8.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/20 00:58 |
| End of Day Share Price | 2025/05/20 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Camp4 Therapeutics Corporation is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Eric Joseph | J.P. Morgan |
| Mani Foroohar | Leerink Partners LLC |
| Edward Tenthoff | Piper Sandler Companies |